IGFBP-rP1 Is a Potential Therapeutic Target in Androgenic Alopecia

    February 2024 in “ Experimental Dermatology
    Lijuan Zhou, Ruiming Hu, Yuan Sheng, Xuchao Wang, Shaohua Qi, Jun Zhao, Ying Miao, Ying Zhao, Feng Xu, Wenyu Wu, Zhongfa Lu, Qing Yang
    Image
    Studysummary In this study, researchers found that IGFBP‐rP1 levels were lower in individuals with androgenic alopecia compared to healthy controls, and subcutaneous injection of IGFBP‐rP1 showed potential in slowing hair loss progression in a mouse model by affecting the hair cycle transition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results